Cargando…
Stem Cells as a Source of Pancreatic Cells for Production of 3D Bioprinted Bionic Pancreas in the Treatment of Type 1 Diabetes
Type 1 diabetes (T1D) is the third most common autoimmune disease which develops due to genetic and environmental risk factors. Often, intensive insulin therapy is insufficient, and patients require a pancreas or pancreatic islets transplant. However, both solutions are associated with many possible...
Autores principales: | Wszoła, Michał, Nitarska, Daria, Cywoniuk, Piotr, Gomółka, Magdalena, Klak, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234129/ https://www.ncbi.nlm.nih.gov/pubmed/34207441 http://dx.doi.org/10.3390/cells10061544 |
Ejemplares similares
-
Bionic Organs: Shear Forces Reduce Pancreatic Islet and Mammalian Cell Viability during the Process of 3D Bioprinting
por: Klak, Marta, et al.
Publicado: (2021) -
Novel Strategies in Artificial Organ Development: What Is the Future of Medicine?
por: Klak, Marta, et al.
Publicado: (2020) -
Bioprinted 3D Bionic Scaffolds with Pancreatic Islets as a New Therapy for Type 1 Diabetes—Analysis of the Results of Preclinical Studies on a Mouse Model
por: Klak, Marta, et al.
Publicado: (2023) -
Irradiation with 365 nm and 405 nm wavelength shows differences in DNA damage of swine pancreatic islets
por: Klak, M., et al.
Publicado: (2020) -
Type 1 diabetes: genes associated with disease development
por: Klak, Marta, et al.
Publicado: (2021)